1. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population
- Author
-
Edward T. O’Leary, Douglas Y. Mah, Kevin G. Friedman, John K. Triedman, Luciana Marcondes, Edward P. Walsh, Omar Meziab, Christina VanderPluym, and Michelle Gurvitz
- Subjects
Tachycardia ,Adult ,Heart Defects, Congenital ,medicine.medical_specialty ,Heart disease ,Adolescent ,Population ,030204 cardiovascular system & hematology ,Single Center ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Physiology (medical) ,Internal medicine ,Atrial Fibrillation ,medicine ,Prevalence ,Humans ,cardiovascular diseases ,030212 general & internal medicine ,Thrombus ,education ,Child ,Atrial tachycardia ,education.field_of_study ,business.industry ,Atrial fibrillation ,Thrombosis ,medicine.disease ,Cross-Sectional Studies ,Atrial Flutter ,cardiovascular system ,Cardiology ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Atrial flutter - Abstract
Introduction Guidelines recommend trans-esophageal echocardiography (TEE) for patients with atrial fibrillation (AF) or atrial flutter (AFL) for > 48 hours, due to risk of intra-cardiac thrombus formation. With growing evidence that AFL in adults with structurally normal hearts has less thrombogenic potential compared to AF, and the need for TEE questioned, we compared prevalence of intra-cardiac thrombus detected by TEE in pediatric and congenital heart disease (CHD) patients presenting in AF and AFL. Methods/results Single center, cross-sectional analysis for unique first-time presentations of patients for either AF, AFL or intra-atrial reentrant tachycardia (IART) between 2000-2019. Patients were categorized by presenting arrhythmia (AF vs. AFL/IART), with exclusion of other forms of atrial tachycardia, hemodynamic instability, chronic anti-coagulation prior to TEE, and presentation for reason other than TEE examination for thrombus. A total of 201 patients had TEE with co-diagnosis of AF or AFL. Of these, 105 patients (29 AF, 76 AFL) met inclusion criteria, with no difference in age between AF (median 24.9 years; IQR 18.6-38.3 years) and AFL/IART (23.3 years; 15.4-38.4 years). The prevalence of thrombus in the entire cohort was 9.5%, with no difference between AF (13.8%) and AFL groups (7.9%), p=0.46. Patients with thrombus demonstrated no difference in age, systemic ventricular function, cardiac complexity, or CHADS2/CHA2DS2VASc score at presentation. Conclusions The risk for intra-cardiac thrombus is high in the pediatric and CHD population, with no apparent distinguishing factors to warrant a change in the recommendations for TEE, with all levels of cardiac complexity being at risk for clot. This article is protected by copyright. All rights reserved.
- Published
- 2020